Senior Imaging Clinical Scientist – PET/SPECT Trials

Scorpion Therapeutics; Indianapolis (IN); On-site; USD 177,000 - 339,000; Full time

Job summary

Scorpion Therapeutics seeks a senior clinical development leader to drive diagnostic radiopharmaceutical programs across oncology, immunology, and cardiovascular disease.

You will define strategies, endpoints, patient populations, and imaging criteria while coordinating studies and regulatory documents with CROs, academia, and software partners. English fluency and 10–15% travel are required.

Qualifications

• PhD in a relevant field.
• 5+ years clinical development experience; 3+ years industry experience.
• GCP and regulatory familiarity.
• Fluency in written/spoken English. Travel 10–15%.

Responsibilities

• Lead integrated clinical development programs for diagnostic radiopharmaceuticals in oncology, immunology, and cardiovascular disease (early to late phase).
• Define clinical strategies, endpoints, patient populations, and imaging criteria.
• Design studies to assess diagnostic accuracy, imaging timing, biomarkers, and performance vs. standard-of-care.
• Serve as scientific expert in molecular imaging modalities (PET, SPECT, CT, MRI); oncology focus and theranostic applications a plus.
• Analyze/interpret imaging data and evaluate imaging biomarkers for stratification and monitoring.
• Collaborate with cross-functional internal teams and external partners (CROs, academia, software developers, scanner manufacturers).
• Author/review clinical and regulatory documents (IBs, protocols/amendments, CSRs, regulatory briefings).
• Communicate findings via presentations, abstracts, and publications.

Skills

Tracer development

Oncology focus

Immunology focus

Cardiology focus

GCP familiarity

Regulatory familiarity

Communication skills

Education

PhD in a relevant field

Job description

Scorpion Therapeutics seeks a senior clinical development leader to drive diagnostic radiopharmaceutical programs across oncology, immunology, and cardiovascular disease.

You will define strategies, endpoints, patient populations, and imaging criteria while coordinating studies and regulatory documents with CROs, academia, and software partners. English fluency and 10–15% travel are required.